Rheumatoid Arthritis News

Drugs used to treat diabetes and obesity, such as GLP-1 receptor agonists, are becoming an important treatment pathway in rheumatology, according to a presenter at the 2024 Association of Women in Rheumatology annual conference.

Biosimilars have shown to be just as effective as original brand name medications in treating rheumatoid arthritis, and the former may be more cost-effective for patients.

Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.

It has been at least 2 years since the first cohort of patients with lupus underwent chimeric antigen receptor T-cell treatment, and, at least so far, for every one of them, each new dawn represents another day spent in full remission.

ORLANDO, Fla. — The aging process can cause a significant decline in the immune system, a process set to impact a growing proportion of the general population and rheumatic patients alike, according to a presenter here.

Forefoot ultrasound adds little value when attempting to predict rheumatoid arthritis in patients with clinically suspect arthralgia, as positive findings there are “rare” without accompanying inflammation in the hands, according to data.

Greater adherence to TNF inhibitor therapy for rheumatoid arthritis led to fewer adverse events, with the optimal adherence threshold being approximately 60% of days covered, according to data published in Clinical Rheumatology.

Makeup not only has cosmetic applications, but medical ones too.

Nearly one-quarter of outpatient visits by patients with systemic autoimmune rheumatic diseases in the United States between 2006 and 2019 resulted in an opioid prescription, according to data published in Arthritis Care & Research.

In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more.